Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner

NCT01114438 is registered in ClinicalTrials.gov with Morphic Medical Inc. as lead sponsor.

NCT NCT01114438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner
Lead sponsor
Morphic Medical Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2010
Completion date
July 31, 2013
Enrollment
45 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 2 diabetes